Authors:
Simon, I
Snow, PB
Marks, LS
Christens-Barry, WA
Epstein, JI
Bluemke, DA
Citation: I. Simon et al., Neural network prediction of prostate tissue composition based on magneticresonance imaging analysis: A pilot study (vol 22, pg 445, 2000), ANAL QUAN C, 23(2), 2001, pp. 150-150
Authors:
Marks, LS
Hess, DL
Dorey, FJ
Macairan, ML
Santos, PBC
Tyler, VE
Citation: Ls. Marks et al., Tissue effects of saw palmetto and finasteride: Use of biopsy cores for insitu quantification of prostatic androgens, UROLOGY, 57(5), 2001, pp. 999-1005
Citation: Aw. Partin et Ls. Marks, Prostate-specific antigen and new serum biomarkers for evaluation of chemopreventive agents, UROLOGY, 57(4A), 2001, pp. 132-136
Authors:
Simon, I
Snow, PB
Marks, LS
Christens-Barry, WA
Epstein, JI
Bluemke, DA
Partin, AW
Citation: I. Simon et al., Neural network prediction of prostate tissue composition eased on magneticresonance imaging analysis - A pilot study, ANAL QUAN C, 22(6), 2000, pp. 445-452
Authors:
Mikolajczyk, SD
Millar, LS
Marker, KM
Wang, TJ
Rittenhouse, HG
Marks, LS
Slawin, KM
Citation: Sd. Mikolajczyk et al., Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia, PROSTATE, 45(3), 2000, pp. 271-276
Citation: Ls. Marks, Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia? Editorial comment, UROLOGY, 56(2), 2000, pp. 266-266
Authors:
Mikolajczyk, SD
Millar, LS
Wang, TJ
Rittenhouse, HG
Wolfert, RL
Marks, LS
Song, WT
Wheeler, TM
Slawin, KM
Citation: Sd. Mikolajczyk et al., "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia, UROLOGY, 55(1), 2000, pp. 41-45
Authors:
Marks, LS
Partin, AW
Epstein, JI
Tyler, VE
Simon, I
Macairan, ML
Chan, TL
Dorey, FJ
Garris, JB
Veltri, RW
Santos, PBC
Stonebrook, KA
deKernion, JB
Citation: Ls. Marks et al., Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia, J UROL, 163(5), 2000, pp. 1451-1456
Authors:
Mikolajczyk, SD
Millar, LS
Wang, TJ
Rittenhouse, HG
Marks, LS
Song, WT
Wheeler, TM
Slawin, KM
Citation: Sd. Mikolajczyk et al., A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue, CANCER RES, 60(3), 2000, pp. 756-759
Citation: Ls. Marks, Transrectal ultrasound with separate measurement of the transition zone volume predicts the short-term outcome after transurethral resection of the prostate - Comment, UROLOGY, 53(5), 1999, pp. 930-930
Citation: Ls. Marks et Ve. Tyler, Saw palmetto extract: Newest (and oldest) treatment alternative for men with symptomatic benign prostatic hyperplasia, UROLOGY, 53(3), 1999, pp. 457-461
Authors:
Mikolajczyk, SD
Millar, LS
Marker, KM
Rittenhouse, HG
Wolfert, RL
Marks, LS
Charlesworth, MC
Tindall, DJ
Citation: Sd. Mikolajczyk et al., Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue, CANCER RES, 59(16), 1999, pp. 3927-3930